Top Markets
#1 Threshold Network Threshold Network +65.04%
#2 TENDIES TENDIES +64.30%
#3 Cash Cat Cash Cat +22.24%
#4 OSK OSK +15.86%
#5 Magma Finance Magma Finance +13.64%
#6 Ape and Pepe Ape and Pepe +13.59%
#7 Asteroid Shiba Asteroid Shiba +13.00%
#8 Falcon Finance Falcon Finance +12.81%
#9 Kite Kite +12.56%
#10 龙虾 (Lobster) 龙虾 (Lobster) +11.22%
Coin of the day
Threshold Network Threshold Network
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock

Neumora Therapeutics, Inc. Common Stock

NMRA
Classifica tra le azioni #17292
Neumora Therapeutics, Inc. is a specialized biopharmaceutical company... Neumora Therapeutics, Inc. is a specialized biopharmaceutical company progressing through clinical trials, dedicated to advancing therapies for a range of neurological, psychiatric, and neurodegenerative conditions. Its most advanced candidate, navacaprant (also known as NMRA-140), is a novel, once-daily oral kappa opioid receptor antagonist currently undergoing Phase 3 clinical trials for the management of major depressive disorder. Additionally, NMRA-511 is in Phase 1 studies, targeting agitation experienced by individuals with Alzheimer's-related dementia. Another compound, NMRA-266, is also in Phase 1 clinical development, aimed at addressing schizophrenia and other related neuropsychiatric conditions. Beyond its clinical programs, Neumora maintains a preclinical pipeline featuring several promising candidates: NMRA-NMDA for schizophrenia, NMRA-CK1d (a CK1d inhibitor initiative) for amyotrophic lateral sclerosis (ALS), NMRA-NLRP3 for specific neurodegenerative ailments, and NMRA-GCase for Parkinson's disease. Tracing its origins to a 2019 incorporation, the company, initially known as RBNC Therapeutics, Inc., adopted its current name, Neumora Therapeutics, Inc., in October 2021. Its corporate headquarters are situated in Watertown, Massachusetts.
Prezzo delle azioni
$1.35
Ultima sincronizzazione: 2026-09-01
Capitalizzazione di mercato
$249.21M
Variazione (1 giorno)
1.13%
Variazione (1 anno)
-22.70%
Paese
US
Scambia Neumora Therapeutics, Inc. Common Stock (NMRA)

Categoria

Healthcare
Il prezzo NMRA con la capitalizzazione del mercato della B
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock
NMRA
$1.35
Capitalizzazione di mercato di Neumora Therapeutics, Inc. Common Stock(NMRA)
Capitalizzazione di mercato: $249.21M
A partire dal September 2026, Neumora Therapeutics, Inc. Common Stock ha una capitalizzazione di mercato pari a $249.21M. Questo rende Neumora Therapeutics, Inc. Common Stock la 17292nd azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Neumora Therapeutics, Inc. Common Stock dal 2023 al 2026
NMRA in paragone con la classifica dei più popolari stocks
Il prezzo per NMRA Attivo B Capitalizzazione del mercato a B Risultati
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock
$28,386.71 $249.21M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.260T +2,110,435.90%
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock
$25,790.27 $249.21M
Apple Inc. Apple Inc.
AAPL
$4.779T +1,917,392.51%
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock
$21,678.81 $249.21M
Alphabet Inc. Alphabet Inc.
GOOG
$4.017T +1,611,707.10%
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock
$20,073.53 $249.21M
Microsoft Corporation Microsoft Corporation
MSFT
$3.719T +1,492,356.06%
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock
$14,757.00 $249.21M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.734T +1,097,074.78%